Published online 9 January 2006 doi:10.1084/jem.20050459
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 1, 153-163
Functional disruption of
4 integrin mobilizes bone marrowderived endothelial progenitors and augments ischemic neovascularization
Gangjian Qin1,
Masaaki Ii1,
Marcy Silver1,
Andrea Wecker1,
Evelyn Bord1,
Hong Ma1,
Mary Gavin1,
David A. Goukassian1,
Young-sup Yoon1,
Thalia Papayannopoulou2,
Takayuki Asahara3,
Marianne Kearney1,
Tina Thorne1,
Cynthia Curry1,
Liz Eaton1,
Lindsay Heyd1,
Deepika Dinesh1,
Raj Kishore1,
Yan Zhu1, and
Douglas W. Losordo1
1 Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135
2 Division of Hematology, Department of Medicine, University of Washington, Seattle, WA 98195
3 Regenerative Medicine and Research, Kobe Institute of Biomedical Research and Innovation/Institute of Physical and Chemical Research, Kobe 650-0047, Japan
CORRESPONDENCE Douglas W. Losordo: Douglas.losordo{at}tufts.edu
The cell surface receptor
4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of
4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of
4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively
4 integrinexpressing cells. In vivo, a single dose of anti
4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti
4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti
4 integrin ex vivo or collected from
4 integrindeficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that
4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of
4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs.
Abbreviations used: Ab, antibody; ß-gal, ß-galactosidase; BMMNC, bone marrow mononuclear cell; BS Bandeiraea simplicifolia; circEPC, circulating endothelial progenitor cell; EC, endothelial cell; EPC, endothelial progenitor cell; FN, fibronectin; HLI, hindlimb ischemia; HPC, hematopoietic progenitor cell; ICAM, intercellular cell adhesion molecule; LAD, left anterior descending; LV, left ventricle; MI, myocardial infarction; PB, peripheral blood; VCAM, vascular cell adhesion molecule.
G. Qin and M. Ii contributed equally to this work.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Caporali, A., Pani, E., Horrevoets, A. J.G., Kraenkel, N., Oikawa, A., Sala-Newby, G. B., Meloni, M., Cristofaro, B., Graiani, G., Leroyer, A. S., Boulanger, C. M., Spinetti, G., Yoon, S. O., Madeddu, P., Emanueli, C.
(2008). Neurotrophin p75 Receptor (p75NTR) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis: Implications for Diabetes-Induced Impaired Neovascularization in Ischemic Limb Muscles. Circ. Res.
103: e15-e26
[Abstract]
[Full Text]
-
Zampetaki, A., Kirton, J. P., Xu, Q.
(2008). Vascular repair by endothelial progenitor cells. Cardiovasc Res
78: 413-421
[Abstract]
[Full Text]
-
Cho, H.-J., Lee, N., Lee, J. Y., Choi, Y. J., Ii, M., Wecker, A., Jeong, J.-O., Curry, C., Qin, G., Yoon, Y.-s.
(2007). Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med.
204: 3257-3269
[Abstract]
[Full Text]
-
Ip, J. E., Wu, Y., Huang, J., Zhang, L., Pratt, R. E., Dzau, V. J.
(2007). Mesenchymal Stem Cells Use Integrin beta1 Not CXC Chemokine Receptor 4 for Myocardial Migration and Engraftment. Mol. Biol. Cell
18: 2873-2882
[Abstract]
[Full Text]
-
Nagano, M., Yamashita, T., Hamada, H., Ohneda, K., Kimura, K.-i., Nakagawa, T., Shibuya, M., Yoshikawa, H., Ohneda, O.
(2007). Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood
110: 151-160
[Abstract]
[Full Text]
-
Chavakis, E., Hain, A., Vinci, M., Carmona, G., Bianchi, M. E., Vajkoczy, P., Zeiher, A. M., Chavakis, T., Dimmeler, S.
(2007). High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells. Circ. Res.
100: 204-212
[Abstract]
[Full Text]
-
Urbanek, K., Cesselli, D., Rota, M., Nascimbene, A., De Angelis, A., Hosoda, T., Bearzi, C., Boni, A., Bolli, R., Kajstura, J., Anversa, P., Leri, A.
(2006). From the Cover: Stem cell niches in the adult mouse heart. Proc. Natl. Acad. Sci. USA
103: 9226-9231
[Abstract]
[Full Text]
-
Asai, J., Takenaka, H., Kusano, K. F., Ii, M., Luedemann, C., Curry, C., Eaton, E., Iwakura, A., Tsutsumi, Y., Hamada, H., Kishimoto, S., Thorne, T., Kishore, R., Losordo, D. W.
(2006). Topical Sonic Hedgehog Gene Therapy Accelerates Wound Healing in Diabetes by Enhancing Endothelial Progenitor Cell-Mediated Microvascular Remodeling. Circulation
113: 2413-2424
[Abstract]
[Full Text]